{
  "variants": [
    {
      "variant": "LRRK2 I2020T",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "reason": "The paper explicitly states that LRRK2 mutations cause Parkinson's disease (PD) and that these variants are in the kinase domain, directly linking them to the disease mechanism."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Binding and enzymatic assays are directly relevant to the disease mechanism involving kinase activity."
        },
        "step_3a": {
          "judgment": "No",
          "reason": "While wild-type LRRK2 is used as a control (normal), the paper does not explicitly mention replicates or multiple experimental repetitions."
        },
        "step_3b": {
          "judgment": "Yes",
          "reason": "The assays (binding and enzymatic) are standard techniques in the field, validated for studying kinase activity."
        },
        "step_3c": {
          "judgment": "No",
          "reason": "The paper does not reference known pathogenic or benign variants as controls for this specific assay."
        },
        "step_4a": {
          "judgment": "No",
          "reason": "The paper does not provide statistical analyses, p-values, or OddsPath calculations for this variant."
        },
        "step_4b": {
          "judgment": "No",
          "reason": "The number of benign/pathogenic variant controls is not explicitly stated, but the study focuses on a single variant."
        },
        "step_4c": {
          "judgment": "No",
          "reason": "No OddsPath values or statistical thresholds are provided for this variant."
        }
      },
      "evidence": {
        "type": "PS3",
        "strength": "supporting"
      }
    },
    {
      "variant": "LRRK2 G2019S",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "reason": "The paper explicitly states that LRRK2 mutations cause PD and that these variants are in the kinase domain, directly linking them to the disease mechanism."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Binding and enzymatic assays are directly relevant to the disease mechanism involving kinase activity."
        },
        "step_3a": {
          "judgment": "No",
          "reason": "While wild-type LRRK2 is used as a control (normal), the paper does not explicitly mention replicates or multiple experimental repetitions."
        },
        "step_3b": {
          "judgment": "Yes",
          "reason": "The assays (binding and enzymatic) are standard techniques in the field, validated for studying kinase activity."
        },
        "step_3c": {
          "judgment": "No",
          "reason": "The paper does not reference known pathogenic or benign variants as controls for this specific assay."
        },
        "step_4a": {
          "judgment": "No",
          "reason": "The paper does not provide statistical analyses, p-values, or OddsPath calculations for this variant."
        },
        "step_4b": {
          "judgment": "No",
          "reason": "The number of benign/pathogenic variant controls is not explicitly stated, but the study focuses on a single variant."
        },
        "step_4c": {
          "judgment": "No",
          "reason": "No OddsPath values or statistical thresholds are provided for this variant."
        }
      },
      "evidence": {
        "type": "PS3",
        "strength": "supporting"
      }
    }
  ]
}